**Core Concept:** Bater syndrome is a rare disorder characterized by progressive external ophthalmoplegia (PEO), myopathy, and often kinesigenic dyskinesias (jerky, involuntary movements triggered by movement). It is associated with mitochondrial DNA mutations, particularly in the MT-ATP6 and MT-ND6 genes, encoding subunits of the mitochondrial electron transport chain (ETC).

**Why the Correct Answer is Right:** The correct answer, **B. Mitochondrial DNA**, represents the genetic basis of Bater syndrome. Mitochondrial DNA mutations lead to defects in the respiratory chain complexes, specifically in the ATP synthase (complex V) and cytochrome c oxidase (complex IV) enzymes. These defects result in decreased ATP production, leading to the characteristic features of Bater syndrome.

**Why Each Wrong Option is Incorrect:**

A. **Nuclear DNA:** This is incorrect because Bater syndrome is primarily caused by mitochondrial DNA mutations, not nuclear DNA mutations.

C. **Mitochondrial ETC Complexes:** This answer is too specific and does not address the genetic basis of the disease.

D. **ATP synthase:** While ATP synthase is affected in Bater syndrome, the correct answer should mention the genetic cause (mitochondrial DNA) rather than the enzyme itself.

**Clinical Pearl:** Bater syndrome serves as an example of the clinical manifestations of mitochondrial DNA mutations, emphasizing the importance of considering genetic causes in cases of isolated PEO or other mitochondrial myopathies.

**Correct Answer:** **B. Mitochondrial DNA**